Yifan Pharmaceutical Co Ltd

Yifan Pharmaceutical Co Ltd’s stock price surges as the company rides the wave of synthetic biology and innovation in the pharmaceutical sector, driven by strategic collaborations and a focus on global expansion.

Yifan Pharmaceutical Co Ltd’s stock has surged 9.17% as of May 29, 2025, driven by anticipation of the ASCO conference and the company’s strategic developments in innovation and international expansion.